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Interventional therapy for tibial arteries is a key part of the vascular specialist armamentarium. Tibial artery interventional
therapy has been proven to lead to limb salvage with low morbidity and mortality in patients with critical limb ischemia
and should be used as a first line treatment mode in the majority of patients, especially in those with significant medical
comorbidities. The exceptions are the patients with extensive tissue loss and infection, where endovascular therapy may
not restore enough flow to achieve rapid healing and limb salvage, and those patients with tissue loss in the setting
extensive, multi-level, occlusive disease, where patency to the completion of wound healing will be unlikely. However,
differences in outcome between available devices are unknown and ways to increase long term patency remain poorly
defined. (J Vasc Surg 2009;50:1219-23.)Less than ten years ago, the majority of the vascular
surgical community believed that interventional therapy for
the infrageniculate vasculature was heresy. Although some
of that negative sentiment still exists today, there are clearly
a growing number of articles supporting interventional
therapy for tibial arteries for critical limb ischemia (CLI).
Many technologies have been introduced that have been
used in the tibial vasculature including angioplasty, cutting
balloon angioplasty, cryoplasty, directional atherectomy,
orbital atherectomy, laser atherectomy, and stenting. Un-
fortunately, no literature to date has compared outcomes
for these different technologies. Clearly, interventional
therapy has worked in this arena, but we have yet to define
who best to use these techniques on and what specific
techniques to use. I will discuss approaches to tibial artery
interventions and review current data regarding outcomes
with angioplasty.
For tibial disease, interventional therapy is a critical part
of the vascular specialists’ armamentarium. The greatest
advantage of interventional therapy for tibial disease is that
it minimizes the morbidity and mortality typically associ-
ated with treating CLI utilizing open operative thera-
pies.1,2 The primary goal in treating CLI is limb salvage and
maintenance of quality of life, not patency, making endo-
vascular treatment the ideal approach. For rest pain, ulcer-
ation andmild to moderate tissue loss endovascular therapy
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doi:10.1016/j.jvs.2009.02.019works exceedingly well. The exceptions are the patients
with extensive tissue loss and infection, where endovascular
therapy may not restore enough flow to achieve rapid
healing and limb salvage, and those patients with tissue loss
in the setting of extensive multi-level occlusive disease,
where patency to the completion of wound healing will be
unlikely. In this setting, tibial bypass with autologous vein
should be used as the first line therapy. For lifestyle limiting
intermittent claudication, most vascular specialists have not
routinely used interventional therapy for tibial vessels as the
primary patency has not been durable enough to justify its
widespread use.
TECHNIQUE
Retrograde contralateral femoral access is preferred as
compared with antegrade access by most interventionalists.
This approach is associated with fewer access-related com-
plications and allows for easier usage of closure devices
when indicated.Many individuals underestimate howmany
complications are predetermined by inappropriate access of
the femoral vessels either too high, above the inguinal
ligament, or too low into the bifurcation, the superficial
femoral artery (SFA) or profunda femorus artery. In select
cases, such as a high narrow aortic bifurcation in calcified
iliac arteries, antegrade access is preferred as it increases
both torquability and pushability in the tibial arteries allow-
ing for successful treatment of occlusions.
Initial imaging is performed with a selective diagnostic
angiography catheter into the distal SFA, when patent, to
obtain adequate detail of the degree and location of tibial
occlusive disease and collateral flow to distal vessels. In
addition, this approach will limit the amount of contrast
necessary to image the tibial and pedal vessels. Imaging
tibial vessels from this location can be performed with less
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nonionic contrast causes the least patient discomfort during
injection, increasing the ability to hold still, and improves
digital subtraction imaging. If proximal SFA disease
doesn’t exist, bringing a 6 French sheath as close as possible
to the level of the popliteal artery allows for better push-
ability for crossing with catheters, wires, and devices and
allows for use of small volumes of dilute contrast to obtain
good imaging after performing an intervention. Adequate
anticoagulation is very important because the tibial vessels
have slower flow of blood and a higher propensity for
thrombus formation than more proximal vessels. Anti-
coagulation is usually achieved with an unfractionated hep-
arin, bolus of 100 units/kg, readministering heparin as
needed to maintain an activated clotting time of greater
than 300 seconds during the procedure.
After angiography, planning the sequence of the pro-
cedure can be very helpful. In many instances a single
stenotic vessel feeding the foot will be found with occlusion
of the remaining tibial vessels. Prior to intervening on a
single patent but stenotic tibial vessel, attempts should be
made to the cross occluded vessels that reconstitute distally
with continuous flow to the foot, even if it is at the pedal
level. Treating chronic total occlusions (CTO) prior to a
single stenotic vessel with continuous runoff to the foot
does not jeopardize the status of the limb when crossing is
unsuccessful. However, after opening a chronically oc-
cluded tibial artery, treatment of the stenotic vessels leads
to more than one tibial vessel directly feeding the ischemic
limb at the completion of the procedure (Fig 1).
Several techniques are helpful in treating tibial chronic
Fig 1. (A) Occluded posterior tibial artery that recon
recanalization and angioplasty.total occlusions. The procedure is most often initiated withan 0.35 floppy angled Glidewire (Terumo, Somerset, NJ)
and a 0.35 Quick-Cross catheter (Spectranectics, Colo-
rado Springs, Colo) for support. Rapidly spinning the
Glidewire like a drill and following the wire with the
catheter for support can be successful in many cases. Some
people prefer to use 0.18 or 0.14 wires for this method,
but I find the support and pushability in the 0.35 wire the
most effective. A second technique to cross involves push-
ing the Quick-Cross catheter and wire together with the
two flush at the end, using the wire to obdurate the catheter
lumen (Fig 2). Because the tibial vessels do not have any
bends in the calf, other than at the origin of the anterior
tibial, this technique works well with a very low risk of
perforation. If either of these two techniques fails, I will use
a subintimal technique by forming a “J” with the floppy
guide wire, similar to what has been extensively described
for the superficial femoral artery (Fig 3A). Due to the small
tibial vessel size, it can be difficult to prevent the “J” from
becoming larger than the vessel diameter (Fig 3B). It is
important to avoid allowing the “J” to get too large as it
usually leads to perforation of the vessel. Limiting the
amount of wire involved in forming the “J” can help to
limit the width of the “J,” thereby limiting the potential for
laceration of the sides of the tibial artery. When a perfora-
tion occurs in the setting of a CTO, it is rarely of any clinical
significance as it will almost always reocclude within a few
minutes when only the wire or catheter has passed extralu-
minally. In the majority of cases, attempting to obtain a
new passage plane, by removing the equipment to above
the top of the occlusion and reattempting to cross the
lesion from the top, will allow for successful crossing and
es at the ankle. (B) Patent posterior tibial artery afterstitutaid in sealing the perforation.
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in the tibial vasculature than in the SFA. Unlike the SFA,
where success rates crossing CTOs can be expected in
excess of 90%, crossing of CTOs is successful less often in
tibials.3-6 This may be due to a higher incidence of circum-
ferential calcification or alternatively the smaller vessel di-
ameter. In selected cases, I have found retrograde tibial
access helpful in crossing total occlusions.7 Using ultra-
sound or fluoroscopic guidance, a micropuncture needle is
utilized to enter the tibial artery distally. The transitional
dilator (or inner cannula) from a micropuncture set can be
used (to keep the entry hole small) without placing a sheath
and then crossing the CTO from below with either a 0.14
or 0.18 wire. Once I have entered the true lumen proxi-
mally, I will snare the wire from above through the cross-
over sheath access. In general, from below it is easier to
cross the CTO and reenter into the true lumen.
I prefer to cross stenotic vessels with a 0.14 hydrophilic
Fig 2. (A) This demonstrates using a 0.35 Quick-Cross catheter
with a 0.35 angled floppy Glidewire flush with end to obdurate
the lumen. (B) Forward pushing on the catheter and wire simul-
taneously is used to cross the occluded vessel.wire. I have a preference for the PT2 wire (Boston Scien-tific, Natick, Mass), which has a hydrophilic coating and,
with this wire, it is easy to form a mild curve in tip. The
properties of this wire allows for excellent steerability in the
tibial vessels even from a contralateral femoral access. Gen-
tle rotation of the wire with a torque device aids in follow-
ing the true lumen into the distal normal vessel (Fig 4).
After crossing a stenosis or occlusion, it is important to
confirm the wire sits in the true lumen distally. Once this is
done, angioplasty is performed with long balloons (10-22
cm length) sized less than or equal to the diameter of the
native vessel, typically starting with 0.14 compatible bal-
Fig 3. (A) A “J loop” formed in a floppy Glidewire in a tibial
vessel. The loop is kept smaller than the diameter of the vessel.
(B) A “J loop” formed in a floppy Glide wire in a tibial vessel,
where the “J loop” has become larger than the vessel diameter and
leads to vessel perforation.loons due to better crossability, and following up with
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reduce cost. Three minute inflations with the minimal
amount of pressure in atmospheres are used to allow the
lesion to dilate. Even for short lesions, long balloons (10
cm), reduce the incidence of flow limiting dissection.When
flow limiting dissection or vasospasm does occur, adminis-
tering large doses (50-400 mcg) of nitroglycerin intra-
arterially can be helpful. When administered below the
popliteal artery, systemic hypotension is uncommon even
in these high doses. After giving vasodilators, the area
should be retreated with a second prolonged angioplasty
for 3-5 minutes. Continued flow limiting dissections after
this approach are quite rare. I have used both directional
atherectomy to excise dissection flaps and coronary balloon
expanded stents to tack down dissection flaps with some
limited success when inadequate flow still exists after ex-
tended inflation angioplasty.
OUTCOMES
The impetus for using interventional therapy for CLI is
based upon the understanding of the significant morbidity
Fig 4. Images A, B, andC depict using a .014 wire with a gentle
curve on the tip rotated with a glide wire to navigate across a
stenosis in a tibial vessel.and mortality using surgical therapy in this patient popula-tion.1 Interventional outcomes for the tibial arteries are
currently poorly defined as long term data is scant. In the
Bypass versus Angioplasty in Severe Ischemia of the Leg
trial, which randomized patients with CLI and appropriate
anatomy for both open and endovascular therapy to surgery
or intervention, 62% of patients with CLI treated interven-
tionally had angioplasty below the SFA. The trial supported
the two therapies as similar at one year for amputation free
survival, all cause mortality, and health related quality of
life.8 A large single center study of 993 patients over a five
year period after tibioperoneal angioplasty reported a limb
salvage rate of 88% with a reintervention rate of 13%.9
Several other recent series have shown good limb salvage
for CLI with tibial angioplasty.4,5,10 A confounding factor
in determining outcomes for tibial intervention is that tibial
interventions are performed for CLI in which the vast
majority of patients will have multilevel disease that is
concomitantly treated and may affect outcome.2,6
What about other technologies for treating tibial artery
disease? Although I have some experience with cryoplasty,
directional atherectomy, orbital atherectomy, and laser
atherectomy as a primary therapy in tibial vessels, I have not
found outcomes with any of these technologies to be
significantly different than balloon angioplasty. Individual
operator skill and experience can lead to acceptable out-
comes with these other technologies; however, data regard-
ing these technologies are limited to short follow up with
conflicting outcomes between small series.
Interventional therapy for tibial arteries is a key part of
the vascular specialist armamentarium. Tibial artery inter-
ventional therapy has been proven to lead to limb salvage
with low morbidity and mortality in patients with critical
limb ischemia and should be used as a first line treatment
mode in the majority of patients, especially in those with
significant medical comorbidities. However, differences in
outcome between available devices are unknown and ways
to increase long term patency remain poorly defined. Two
settings exist where operative therapy should be used first
with tibial bypass over interventional modalities. The first is
when a total occlusion continuously includes the superficial
femoral artery, popliteal artery, and tibial arteries. Interven-
tional therapies are generally not durable enough to achieve
wound healing in this setting. The second setting is for
patients when the extent of tissue loss necessitates extended
forefoot amputation or debridement, where interventional
therapy may not restore enough flow to achieve limb sal-
vage. In any patient with tissue loss treated with revascular-
ization, it is imperative that the vascular specialist be in-
volved in the evaluation of the wound following the
procedure to assure that wound healing is progressing as
expected and so that changes in the wound status, which
may imply problems with the revascularization, can be
identified and addressed rapidly.
AUTHOR CONTRIBUTIONS
Conception and design: SL
Analysis and interpretation: SL
Data collection: SL
JOURNAL OF VASCULAR SURGERY
Volume 50, Number 5 Lyden 1223Writing the article: SL
Critical revision of the article: SL
Final approval of the article: SL
Statistical analysis: SL
Obtained funding: SL
Overall responsibility: SL
REFERENCES
1. Nehler MR, Hiatt WR, Taylor LM Jr. Is revascularization and limb
salvage always the best treatment for critical limb ischemia? J Vasc Surg
2003;37:704-8.
2. DeRubertis BG, Faries PL, McKinsey JF, Chaer RA, Pierce M, Kar-
wowski J, et al. Shifting paradigms in the treatment of lower extremity
vascular disease: a report of 1000 percutaneous interventions. Ann Surg
2007;246:415-22; discussion 22-4.
3. Tartari S, Zattoni L, Rizzati R, Aliberti C, Capello K, Sacco A, et al.
Subintimal angioplasty as the first-choice revascularization technique
for infrainguinal arterial occlusions in patients with critical limb isch-
emia. Ann Vasc Surg 2007;21:819-28.
4. Tefera G, Hoch J, Turnipseed WD. Limb-salvage angioplasty in vascu-
lar surgery practice. J Vasc Surg 2005;41:988-93.5. Giles KA, Pomposelli FB, Hamdan AD, Blattman SB, Panossian H,
Schermerhorn ML. Infrapopliteal angioplasty for critical limb ischemia:relation of TransAtlantic InterSociety Consensus class to outcome in
176 limbs. J Vasc Surg 2008;48:128-36.
6. Met R, Van Lienden KP, KoelemayMJ, Bipat S, Legemate DA, Reekers
JA. Subintimal angioplasty for peripheral arterial occlusive disease: a
systematic review. Cardiovasc Intervent Radiol 2008;31:687-97.
7. Spinosa DJ, HarthunNL, Bissonette EA, CageD, LeungDA, Angle JF,
et al. Subintimal arterial flossing with antegrade-retrograde intervention
(SAFARI) for subintimal recanalization to treat chronic critical limb
ischemia. J Vasc Interv Radiol 2005;16:37-44.
8. Adam DJ, Beard JD, Cleveland T, Bell J, Bradbury AW, Forbes
JF, et al. Bypass versus angioplasty in severe ischaemia of the leg
(BASIL): multicentre, randomised controlled trial. Lancet 2005;
366:1925-34.
9. Faglia E, Dalla Paola L, Clerici G, Clerissi J, Graziani L, Fusaro M, et
al. Peripheral angioplasty as the first-choice revascularization proce-
dure in diabetic patients with critical limb ischemia: prospective
study of 993 consecutive patients hospitalized and followed between
1999 and 2003. Eur J Vasc Endovasc Surg 2005;29:620-7.
10. Gargiulo M, Maioli F, Ceccacci T, Morselli-Labate AM, Faggioli G,
Freyrie A, et al. What’s next after optimal infrapopliteal angioplasty?
Clinical and ultrasonographic results of a prospective single-center
study. J Endovasc Ther 2008;15:363-9.Submitted Feb 8, 2009; accepted Feb 11, 2009.
